Search clinical trials for: Comparator: placebo (unspecified) / Duration of Treatment: 17 Weeks

Total 192 results

Merck Sharp & Dohme LLC

Completed

MK0524A Phase IIb Study (0524A-011)(COMPLETED)

Flushing
Merck Sharp & Dohme LLC

Completed

MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)

Hypercholesterolemia
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

Intra-abdominal Infection
Organon and Co

Completed

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

Androgenetic Alopecia
Organon and Co

Completed

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Osteoporosis, Postmenopausal
Merck Sharp & Dohme LLC

Completed

A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)

Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC

Completed

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

Type 2 Diabetes Mellitus
Organon and Co

Completed

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

HDL Cholesterol
Merck Sharp & Dohme LLC

Completed

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Arthritis, Rheumatoid
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Recurrent Low Back Pain
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Recurrent Low Back Pain
Merck Sharp & Dohme LLC

Completed

Endpoint Validation Study (0524A-015)

Flushing
Organon and Co

Completed

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

Coronary Disease
H. Lundbeck A/S

Terminated

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

Primary Insomnia
H. Lundbeck A/S

Terminated

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

Primary Insomnia
Organon and Co

Completed

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

Benign Prostatic Hyperplasia
Organon and Co

Completed

Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

Hypercholesterolemia
Organon and Co

Completed

A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

Hypercholerolemia
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Complicated Intra-Abdominal Infections
Merck Sharp & Dohme LLC

Completed

Effect of MK0524A on Flushing Caused by Niacin (0524A-056)

Flushing
Merck Sharp & Dohme LLC

Terminated

Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)

Diabetes Mellitus Type 2
Merck Sharp & Dohme LLC

Terminated

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Diabetes Mellitus, Type 2
Organon and Co

Completed

Eze/Simva Switch Study in Diabetics (0653A-807)

Diabetes Mellitus, Type 2
Organon and Co

Terminated

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

Cardiovascular Diseases | Diabetes Mellitus
Organon and Co

Completed

Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

Diabetes Mellitus, Type 2
Organon and Co

Completed

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Asthma
Merck Sharp & Dohme LLC

Completed

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Foot Infections in Diabetic Patients
Organon and Co

Completed

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Rhinitis Allergic
Merck Sharp & Dohme LLC

Completed

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)

HIV Infections
Merck Sharp & Dohme LLC

Terminated

A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Adenomatous Polyposis Coli
Merck Sharp & Dohme LLC

Terminated

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Metabolic X Syndrome Dyslipidemia
Organon and Co

Completed

Health Assessment Study (0954-946)

Hypertension
Organon and Co

Completed

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

Postmenopausal Osteoporosis
University of Colorado, Denver

Recruiting

Should Graf IIc Hips be Treated for 12 Weeks

Developmental Dysplasia of Hip

United States
H. Lundbeck A/S

Completed

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

Primary Insomnia
NovaCardia, Inc.
Merck Sharp & Dohme LLC

Completed

Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients

Renal Impairment | Congestive Heart Failure
Merck Sharp & Dohme LLC

Completed

Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)

Pain, Postoperative Arthroscopy
NovaCardia, Inc.
Merck Sharp & Dohme LLC

Completed

Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy (REACH UP)

Heart Failure, Congestive
Göteborg University
Karolinska Institutet; Uppsala University; Umeå University; Vastra Gotaland Region

Unknown

Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) (OPTIMIZE-HFPEF)

Heart Failure, Diastolic

Sweden
Organon and Co

Completed

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

Chronic Low Back Pain
Boehringer Ingelheim

Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Hepatitis C, Chronic

United States, Australia, Belgium, Canada, France, Germany, Greece, Italy, New Zealand, Portugal, Spain, United Kingdom
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

Migraine
Merck Sharp & Dohme LLC

Completed

A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)

Pneumonia | Infection
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)

Migraine
Organon and Co

Completed

Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

Migraine
Organon and Co

Completed

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Renal Disorder
Organon and Co

Completed

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

Migraine

3

Subscribe